Latest News & Features
Big Pharma
Eli Lilly has entered into a $35m global licensing and research agreement with biotech company Avidity Biosciences. 25 April 2019
Generics
A US health insurance provider is suing a subsidiary of Johnson & Johnson for filing “sham” patent litigation in a bid to stop generic forms of a prostate cancer treatment from entering the market. 25 April 2019
Americas
The Federal Circuit has upheld a finding of the US Patent and Trademark Office, which rendered a Purdue Pharma oxycodone patent ineligible. 23 April 2019
Medtech
Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences. 23 April 2019
Big Pharma
Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties. 23 April 2019
Americas
ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format. 23 April 2019
Generics
The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs. 18 April 2019
Big Pharma
Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report. 17 April 2019
Americas
The University of Pennsylvania has treated two cancer patients with CRISPR/Cas 9, a gene-editing technology that allows precise modifications to DNA. 17 April 2019
Americas
Contract drug manufacturer Catalent has agreed to acquire Paragon Bioservices, a viral vector development and manufacturing partner for gene therapies, for $1.2 billion. 17 April 2019